This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Background and Objective To identify clinical, ECG, and blood-based biomarkers associated with atrial fibrillation (AF) detection after ischaemic stroke or TIA that could help inform patient selection for cardiac monitoring.
Methods We performed a systematic review and meta-analysis and searched electronic databases for cohort studies from January 15, 2000, to January 15, 2020. The outcome was AF ≥30 seconds within 1 year after ischemic stroke/TIA. We used random effects models to create summary estimates of risk. Risk of bias was assessed using the Quality in Prognostic Studies tool.
Results We identified 8,503 studies, selected 34 studies, and assessed 69 variables (42 clinical, 20 ECG, and 7 blood-based biomarkers). The studies included 11,569 participants and AF was detected in 1,478 (12.8%). Overall, risk of bias was moderate. Variables associated with increased likelihood of AF detection are older age (odds ratio [OR] 3.26, 95% confidence interval [CI] 2.35–4.54), female sex (OR 1.47, 95% CI 1.23–1.77), a history of heart failure (OR 2.56, 95% CI 1.87–3.49), hypertension (OR 1.42, 95% CI 1.15–1.75) or ischemic heart disease (OR 1.80, 95% CI 1.34–2.42), higher modified Rankin Scale (OR 6.13, 95% CI 2.93–12.84) or National Institutes of Health Stroke Scale score (OR 2.50, 95% CI 1.64–3.81), no significant carotid/intracranial artery stenosis (OR 3.23, 95% CI 1.14–9.11), no tobacco use (OR 1.93, 95% CI 1.48–2.51), statin therapy (OR 2.07, 95% CI 1.14–3.73), stroke as index diagnosis (OR 1.59, 95% CI 1.17–2.18), systolic blood pressure (OR 1.61, 95% CI 1.16–2.22), IV thrombolysis treatment (OR 2.40, 95% CI 1.83–3.16), atrioventricular block (OR 2.12, 95% CI 1.08–4.17), left ventricular hypertrophy (OR 2.21, 95% CI 1.03–4.74), premature atrial contraction (OR 3.90, 95% CI 1.74–8.74), maximum P-wave duration (OR 3.19, 95% CI 1.40–7.25), PR interval (OR 2.32, 95% CI 1.11–4.83), P-wave dispersion (OR 7.79, 95% CI 4.16–14.61), P-wave index (OR 3.44, 95% CI 1.87–6.32), QTc interval (OR 3.68, 95% CI 1.63–8.28), brain natriuretic peptide (OR 13.73, 95% CI 3.31–57.07), and high-density lipoprotein cholesterol (OR 1.49, 95% CI 1.17–1.88) concentrations. Variables associated with reduced likelihood are minimum P-wave duration (OR 0.53, 95% CI 0.29–0.98), low-density lipoprotein cholesterol (OR 0.73, 95% CI 0.57–0.93), and triglyceride (OR 0.51, 95% CI 0.41–0.64) concentrations.
Discussion We identified multimodal biomarkers that could help guide patient selection for cardiac monitoring after ischaemic stroke/TIA. Their prognostic utility should be prospectively assessed with AF detection and recurrent stroke as outcomes.
Glossary
- AF=
- atrial fibrillation;
- ANP=
- atrial natriuretic peptide;
- BNP=
- brain natriuretic peptide;
- CI=
- confidence interval;
- IHD=
- ischemic heart disease;
- IVT=
- IV thrombolysis;
- LDL=
- low-density lipoprotein;
- LVH=
- left ventricular hypertrophy;
- MRproANP=
- midregional pro-atrial natriuretic peptide;
- mRS=
- modified Rankin Scale;
- NIHSS=
- National Institutes of Health Stroke Scale;
- NT-proBNP=
- N-terminal pro-brain natriuretic peptide;
- OR=
- odds ratio;
- PAC=
- premature atrial contraction;
- PWD=
- P-wave dispersion;
- SBP=
- systolic blood pressure
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
↵* These authors contributed equally and are co–first authors.
↵† These authors contributed equally and are co–last authors.
CME Course: NPub.org/cmelist
- Received March 3, 2021.
- Accepted in final form August 18, 2021.
- © 2021 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
- Reader Response: Biomarkers for Atrial Fibrillation Detection After Stroke
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
